AMLX AMYLYX PHARMACEUTICALS INC More: the full row for AMYLYX PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 889,073 shares; 2025Q1: 2,426,436 shares; 2025Q2: 3,260,570 shares; 2025Q3: 4,604,878 shares; 2025Q4: 4,496,487 shares; 2026Q1: 4,349,885 shares; 2026Q2: 4,624,101 shares; 2026Q3: 4,471,356 shares 4,471,356 $130M 19.05% -152,745 Timeline ABVX ABIVAX SA More: the full row for ABIVAX SA Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 653,071 shares; 2025Q1: 552,926 shares; 2025Q2: 622,479 shares; 2025Q3: 801,224 shares; 2025Q4: 649,179 shares; 2026Q1: 542,696 shares; 2026Q2: 518,865 shares; 2026Q3: 529,313 shares 529,313 $52.4M 7.67% +10,448 Timeline IMMX IMMIX BIOPHARMA INC More: the full row for IMMIX BIOPHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 2,999,169 shares; 2026Q1: 3,693,585 shares; 2026Q2: 4,658,429 shares; 2026Q3: 4,661,115 shares 4,661,115 $48.5M 7.1% +2,686 Timeline PHVS PHARVARIS N V More: the full row for PHARVARIS N V Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 886,332 shares; 2025Q4: 1,140,033 shares; 2026Q1: 1,201,402 shares; 2026Q2: 1,314,122 shares; 2026Q3: 1,393,956 shares 1,393,956 $44.2M 6.47% +79,834 Timeline PCVX VAXCYTE INC More: the full row for VAXCYTE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 204,285 shares; 2025Q1: 232,295 shares; 2025Q2: 544,221 shares; 2025Q3: 788,441 shares; 2025Q4: 798,940 shares; 2026Q1: 824,532 shares; 2026Q2: 852,914 shares; 2026Q3: 772,258 shares 772,258 $43.9M 6.43% -80,656 Timeline CELC CELCUITY INC More: the full row for CELCUITY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,063,783 shares; 2025Q1: 1,093,677 shares; 2025Q2: 1,185,520 shares; 2025Q3: 473,828 shares; 2025Q4: 317,095 shares; 2026Q1: 281,904 shares; 2026Q2: 370,318 shares; 2026Q3: 513,847 shares 513,847 $40.9M 5.98% +143,529 Timeline IRON DISC MEDICINE INC More: the full row for DISC MEDICINE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 509,406 shares; 2025Q1: 518,177 shares; 2025Q2: 396,115 shares; 2025Q3: 340,897 shares; 2025Q4: 298,429 shares; 2026Q1: 449,926 shares; 2026Q2: 524,730 shares; 2026Q3: 612,661 shares 612,661 $40.1M 5.87% +87,931 Timeline CADL CANDEL THERAPEUTICS INC More: the full row for CANDEL THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 2,896,588 shares; 2026Q2: 3,303,686 shares; 2026Q3: 3,476,206 shares 3,476,206 $36.3M 5.31% +172,520 Timeline JAZZ JAZZ PHARMACEUTICALS PLC More: the full row for JAZZ PHARMACEUTICALS PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 206,952 shares; 2025Q3: 300,610 shares; 2025Q4: 248,070 shares; 2026Q1: 162,961 shares; 2026Q2: 160,938 shares; 2026Q3: 150,340 shares 150,340 $34.8M 5.1% -10,598 Timeline MNPR MONOPAR THERAPEUTICS INC More: the full row for MONOPAR THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 155,370 shares; 2025Q4: 325,701 shares; 2026Q1: 345,626 shares; 2026Q2: 311,976 shares; 2026Q3: 312,350 shares 312,350 $24.9M 3.64% +374 Timeline VIR VIR BIOTECHNOLOGY INC More: the full row for VIR BIOTECHNOLOGY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 770,643 shares; 2026Q3: 2,040,422 shares 2,040,422 $22.8M 3.34% +1,269,779 Timeline TRVI TREVI THERAPEUTICS INC More: the full row for TREVI THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,052,043 shares; 2026Q3: 1,573,876 shares 1,573,876 $22.5M 3.3% +521,833 Timeline XFOR X4 PHARMACEUTICALS INC More: the full row for X4 PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 5,800,530 shares; 2026Q1: 6,456,646 shares; 2026Q2: 6,973,343 shares; 2026Q3: 7,366,442 shares 7,366,442 $21.4M 3.13% +393,099 Timeline ALMS ALUMIS INC More: the full row for ALUMIS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 3,135,953 shares; 2026Q1: 3,202,075 shares; 2026Q2: 2,915,443 shares; 2026Q3: 2,855,811 shares 2,855,811 $21.1M 3.09% -59,632 Timeline SGMT SAGIMET BIOSCIENCES INC More: the full row for SAGIMET BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,479,918 shares; 2026Q3: 2,002,813 shares 2,002,813 $19.8M 2.9% +522,895 Timeline DYN DYNE THERAPEUTICS INC More: the full row for DYNE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 1,455,429 shares; 2025Q3: 2,674,469 shares; 2025Q4: 1,788,616 shares; 2026Q1: 966,609 shares; 2026Q2: 1,057,493 shares; 2026Q3: 837,175 shares 837,175 $13.5M 1.97% -220,318 Timeline ANRO ALTO NEUROSCIENCE INC More: the full row for ALTO NEUROSCIENCE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 88,999 shares; 2026Q2: 182,829 shares; 2026Q3: 518,109 shares 518,109 $13.2M 1.94% +335,280 Timeline RARE ULTRAGENYX PHARMACEUTICAL IN More: the full row for ULTRAGENYX PHARMACEUTICAL IN Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 758,771 shares 758,771 $11.4M 1.67% new Timeline ZURA ZURA BIO LTD More: the full row for ZURA BIO LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 739,960 shares; 2026Q2: 2,101,119 shares; 2026Q3: 2,032,454 shares 2,032,454 $8.46M 1.24% -68,665 Timeline IKT INHIBIKASE THERAPEUTICS INC More: the full row for INHIBIKASE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 3,856,799 shares; 2026Q1: 3,863,445 shares; 2026Q2: 3,869,056 shares; 2026Q3: 3,869,056 shares 3,869,056 $7.95M 1.16% 0 Timeline OCS OCULIS HOLDING AG More: the full row for OCULIS HOLDING AG Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 516,761 shares; 2026Q1: 516,761 shares; 2026Q2: 684,880 shares; 2026Q3: 847,444 shares 847,444 $7.92M 1.16% +162,564 Timeline ERAS ERASCA INC More: the full row for ERASCA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 514,309 shares 514,309 $7.54M 1.1% new Timeline LTGO LATIGO BIOTHERAPEUTICS INC More: the full row for LATIGO BIOTHERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 300,355 shares 300,355 $5.02M 0.73% new Timeline MSLE SATELLOS BIOSCIENCE INC More: the full row for SATELLOS BIOSCIENCE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 350,000 shares; 2026Q2: 350,000 shares; 2026Q3: 516,800 shares 516,800 $4.39M 0.64% +166,800 Timeline